Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VUF11207 fumarate is an agonist of CXCR7 and a high-potency ligand of CXCR7 (pKi: 8.1).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 36.00 | |
2 mg | In stock | $ 50.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 139.00 | |
25 mg | In stock | $ 287.00 | |
50 mg | In stock | $ 497.00 | |
100 mg | In stock | $ 716.00 | |
200 mg | In stock | $ 996.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | VUF11207 fumarate is an agonist of CXCR7 and a high-potency ligand of CXCR7 (pKi: 8.1). |
Targets&IC50 | CXCR7:8.1 (pki) |
Molecular Weight | 586.65 |
Formula | C31H39FN2O8 |
CAS No. | 1785665-61-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 247 mg/mL (421.03 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VUF11207 fumarate 1785665-61-3 Autophagy GPCR/G Protein Immunology/Inflammation CXCR Arrestin VUF11207 Inhibitor TnF?α osteoclast precursor cells VUF-11207 LPS CXC chemokine receptors inhibit osteoclastogenesis VUF-11207 fumarate VUF 11207 Fumarate bone resorption VUF 11207 VUF-11207 Fumarate RANKL VUF11207 Fumarate inhibitor